Stuart Avery

1.2k total citations
14 papers, 791 citations indexed

About

Stuart Avery is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Stuart Avery has authored 14 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Pharmacology. Recurrent topics in Stuart Avery's work include Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (2 papers) and Renal and related cancers (2 papers). Stuart Avery is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (2 papers) and Renal and related cancers (2 papers). Stuart Avery collaborates with scholars based in United Kingdom, Singapore and Australia. Stuart Avery's co-authors include H. D. M. Moore, Pete Kaiser, Lisa Rothwell, Jim Kaufman, John R. Young, Peter W. Andrews, Gaetano Zafarana, Virgil E.J.C. Schijns, Nat Bumstead and Mick Watson and has published in prestigious journals such as Cell stem cell, Stem Cells and American Journal of Roentgenology.

In The Last Decade

Stuart Avery

14 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Avery United Kingdom 10 368 187 130 124 109 14 791
Mary S. Pampusch United States 21 453 1.2× 168 0.9× 164 1.3× 82 0.7× 15 0.1× 39 899
Björn Jacobsen Switzerland 12 206 0.6× 143 0.8× 77 0.6× 31 0.3× 43 0.4× 26 682
Eui‐Soon Park South Korea 16 583 1.6× 328 1.8× 49 0.4× 72 0.6× 20 0.2× 21 995
Rachel Young United Kingdom 19 593 1.6× 148 0.8× 31 0.2× 89 0.7× 31 0.3× 30 1.0k
Zhijie Lin China 19 387 1.1× 172 0.9× 20 0.2× 26 0.2× 22 0.2× 49 886
Miles K. Yamanaka United States 15 415 1.1× 51 0.3× 42 0.3× 85 0.7× 18 0.2× 19 904
Pierre‐Philippe Luyet Switzerland 11 464 1.3× 92 0.5× 19 0.1× 40 0.3× 57 0.5× 19 821
Eva Hellmén Sweden 21 429 1.2× 119 0.6× 31 0.2× 92 0.7× 15 0.1× 39 1.3k
Daniel M. Appledorn United States 17 502 1.4× 301 1.6× 37 0.3× 39 0.3× 11 0.1× 27 978

Countries citing papers authored by Stuart Avery

Since Specialization
Citations

This map shows the geographic impact of Stuart Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Avery more than expected).

Fields of papers citing papers by Stuart Avery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Avery. The network helps show where Stuart Avery may publish in the future.

Co-authorship network of co-authors of Stuart Avery

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Avery. A scholar is included among the top collaborators of Stuart Avery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Avery. Stuart Avery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ho, Lena, Shawn Y.X. Tan, Sheena Wee, et al.. (2015). ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway. Cell stem cell. 17(4). 435–447. 145 indexed citations
2.
Ho, Lena, Shawn Y.X. Tan, Sheena Wee, et al.. (2015). ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway. Cell stem cell. 17(5). 635–635. 10 indexed citations
3.
Avery, Stuart, Adam J. Hirst, Duncan Baker, et al.. (2013). BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell Cultures. Stem Cell Reports. 1(5). 379–386. 115 indexed citations
4.
Avery, Stuart, Gaetano Zafarana, Paul J. Gokhale, & Peter W. Andrews. (2010). The Role of SMAD4 in Human Embryonic Stem Cell Self-Renewal and Stem Cell Fate. Stem Cells. 28(5). 863–873. 36 indexed citations
5.
Zafarana, Gaetano, et al.. (2009). Specific Knockdown of OCT4 in Human Embryonic Stem Cells by Inducible Short Hairpin RNA Interference  . Stem Cells. 27(4). 776–782. 46 indexed citations
6.
7.
Avery, Stuart, et al.. (2006). The Regulation of Self-Renewal in Human Embryonic Stem Cells. Stem Cells and Development. 15(5). 729–740. 55 indexed citations
8.
Avery, Stuart, et al.. (2006). Mechanisms Controlling Self-renewal and Pluripotency in Human Embryonic Stem Cells. Biotechnology and Genetic Engineering Reviews. 23(1). 273–290. 2 indexed citations
9.
Kaiser, Pete, Tuang Yeow Poh, Lisa Rothwell, et al.. (2005). A Genomic Analysis of Chicken Cytokines and Chemokines. Journal of Interferon & Cytokine Research. 25(8). 467–484. 179 indexed citations
10.
11.
Rothwell, Lisa, Pete Kaiser, Stuart Avery, & Sucharitha Balu. (2004). Evolution of the interleukins. Dev Comp Immunol. 2 indexed citations
12.
13.
Liberman, Laura, Maureen F. Zakowski, Stuart Avery, et al.. (1999). Complete percutaneous excision of infiltrating carcinoma at stereotactic breast biopsy: how can tumor size be assessed?. American Journal of Roentgenology. 173(5). 1315–1322. 25 indexed citations
14.
Avery, Stuart, et al.. (1995). Huntington's disease: diagnosis by amplification of the CAG repeat.. PubMed. 108(995). 78–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary S. Pampusch Breakdown of academic impact, for papers by Björn Jacobsen Breakdown of academic impact, for papers by Eui‐Soon Park Breakdown of academic impact, for papers by Rachel Young Breakdown of academic impact, for papers by Zhijie Lin Breakdown of academic impact, for papers by Miles K. Yamanaka Breakdown of academic impact, for papers by Pierre‐Philippe Luyet Breakdown of academic impact, for papers by Eva Hellmén Breakdown of academic impact, for papers by Daniel M. Appledorn
Rankless by CCL
2026